8-Aminoquinoline Therapy for Latent Malaria
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
The technical genesis and practice of 8-aminoquinoline therapy of latent malaria offer singular scientific, clinical, and public health insights. The 8-aminoquinolines brought revolutionary scientific discoveries, dogmatic practices, benign neglect, and, finally, enduring promise against endemic malaria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Primaquine efficacy is further complicated by both impacts of partner blood schizontocides and natural polymorphisms of cytochrome P450 2D6 impairing the necessary metabolic processing of primaquine [39–42].”
In the citing paper
“Primaquine efficacy is further complicated by both impacts of partner blood schizontocides and natural polymorphisms of cytochrome P450 2D6 impairing the necessary metabolic processing of primaquine [39–42].”
In the citing paper
“In countries where P. vivax is endemic, the only antimalarial drugs currently available for radical cure are primaquine and, more recently, tafenoquine [3].”
In the citing paper
“Hypnozoites are not sensitive to most schizonticidal drugs used to kill the blood stages of the parasite and treat the acute febrile illness [3].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantifying the Number of Pregnancies at Risk of Malaria in 2007: A Demographic Study
Dellicour, S., Tatem, A. J., Guerra, C. A., Snow, R. W., & ter Kuile, F. O. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000221 · Cited by 490
Battle, K. E., Lucas, T. C. D., Nguyen, M., Howes, R. E., Nandi, A. K., Twohig, K. A., Pfeffer, D. A., Cameron, E., Rao, P. C., Casey, D., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31096-7 · Cited by 409
Evidence and Implications of Mortality Associated with Acute Plasmodium vivax Malaria
Baird, J. K. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00074-12 · Cited by 398
Self-citationKinetics and mechanism of the oxidation of human deoxyhemoglobin by nitrites.
Doyle, M. P., Pickering, R. A., DeWeert, T. M., Hoekstra, J. W., & Pater, D. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43285-1 · Cited by 334
McGready, R., Lee, S., Wiladphaingern, J., Ashley, E., Rijken, M., Boel, M., Simpson, J., Paw, M., Pimanpanarak, M., Mu, O., et al. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70339-5 · Cited by 228
Malaria in pregnancy in the Asia-Pacific region
Rijken, M. J., McGready, R., Boel, M. E., Poespoprodjo, R., Singh, N., Syafruddin, D., Rogerson, S., & Nosten, F. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70315-2 · Cited by 181
Moore, K. A., Simpson, J. A., Scoullar, M. J. L., McGready, R., & Fowkes, F. J. I. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30340-6 · Cited by 165
Prevention of malaria in pregnancy
Desai, M., Hill, J., Fernandes, S., Walker, P., Pell, C., Gutman, J., Kayentao, K., Gonzalez, R., Webster, J., Greenwood, B., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30064-1 · Cited by 153
Poespoprodjo, J. R., Fobia, W., Kenangalem, E., Lampah, D. A., Warikar, N., Seal, A., McGready, R., Sugiarto, P., Tjitra, E., Anstey, N. M., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/586743 · Cited by 148
Watson, J., Taylor, W. R. J., Bancone, G., Chu, C. S., Jittamala, P., & White, N. J. (2018) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0006440 · Cited by 77
Research works printed but not linked: 322
- World Health Organization. 2015. Control and elimination of Plasmodium vivax malaria: a technical brief, p 64. World Health Organization, Geneva, Switzerland.
- 10.1016/B978-0-12-397900-1.00003-7 · DOI · Paper page
- 10.1371/journal.pntd.0003071 · DOI · Paper page
- 10.4269/ajtmh.17-0131 · DOI
- 10.4269/ajtmh.16-0171 · DOI
- Young MD. 1944. Studies on the periodicity of induced Plasmodium vivax. J Natl Malar Soc 3:237–247.
- 10.1016/B978-0-12-397900-1.00002-5 · DOI · Paper page
- 10.1136/bmj.2.2115.77 · doi:10.1136/bmj.2.2115.77
- 10.1093/jac/36.5.857 · DOI
- Sinton JA. 1930. A suggested standard treatment of malaria based upon the results of the controlled investigation of over 3,700 cases. Ind Med Gaz 65:603–620.
- Slater L. 2013. War and disease: biomedical research on malaria in the twentieth century. Rutgers University Press, New Brunswick, NJ.
- 10.1128/AAC.01296-10 · DOI
- Shannon JA. 1946. Chemotherapy in malaria. Bull N Y Acad Med 22:345–357.
- Wiselogle FY. 1946. A survey of antimalarial drugs 1941–1945. J. W. Edwards, Ann Arbor, MI.
- Carson PE, Hohl R, Nora MV, Parkhurst GW, Ahmad T, Scanlan S, Frischer H. 1981. Toxicology of the 8-aminoquinolines and genetic factors associated with their toxicity in man. Bull World Health Organ 59:427–437.
- 10.1353/pbm.2013.0035 · doi:10.1353/pbm.2013.0035
- 10.1179/2047773215Y.0000000016 · DOI
- 10.1371/journal.pmed.1001339 · DOI · Paper page
- 10.1186/s12936-018-2248-y · DOI · Paper page
- 10.1371/journal.pmed.1002379 · DOI · Paper page
- 10.1186/1475-2875-11-280 · DOI · Paper page
- 10.1016/j.tmaid.2015.04.006 · doi:10.1016/j.tmaid.2015.04.006
- 10.1128/AAC.01879-12 · DOI
- 10.1186/s12916-015-0535-9 · DOI
- 10.4269/ajtmh.16-0410 · DOI
- 10.1093/cid/ciy319 · DOI · Paper page
- Coatney GR, Collins WE, Warren MCW, Contacos PG, 1971. The primate malarias, p 366. Stock no. 1744-0005. U.S. Government Printing Office, Washington, DC.
- Lysenko AJ, Beljaev AE, Rybalka VM. 1977. Population studies of Plasmodium vivax. 1. The theory of polymorphism of sporozoites and epidemiological phenomena of tertian malaria. Bull World Health Organ 55:541–549.
- Rybalka VM, Beljaev AE, Lysenko AJ. 1977. Population studies of Plasmodium vivax. 2. Distribution of manifestations in foci of tertian malaria. Bull World Health Organ 55:551–556.
- 10.1086/512242 · DOI · Paper page
- 10.1016/S0035-9203(48)80006-4 · doi:10.1016/s0035-9203(48)80006-4
- 10.4269/ajtmh.1982.31.24 · doi:10.4269/ajtmh.1982.31.24
- 10.4269/ajtmh.1982.31.609 · doi:10.4269/ajtmh.1982.31.609
- 10.4269/ajtmh.1983.32.231 · DOI
- 10.1186/s12936-017-1759-2 · DOI
- 10.1128/CMR.18.3.570-581.2005 · DOI · Paper page
- 10.1186/s12936-016-1605-y · DOI
- 10.1128/CMR.00027-07 · DOI · Paper page
- World Health Organization. 1961. Chemotherapy of malaria: report of a technical meeting, 14-19 November 1960, p 92. Technical report series no. 226. World Health Organization, Geneva, Switzerland.
- 10.1136/bmj.2.5348.27 · doi:10.1136/bmj.2.5348.27
- Hendrickse RG. 1976. The quartan malaria nephrotic syndrome. Adv Nephrol 6:229–233.
- 10.1371/journal.pntd.0004195 · DOI · Paper page
- 10.3201/eid2308.161582 · DOI
- 10.4269/ajtmh.2006.75.402 · DOI · Paper page
- 10.1016/0035-9203(61)90103-1 · DOI
- 10.1128/aac.44.6.1680-1685.2000 · DOI · Paper page
- 10.1086/379714 · DOI
- 10.1016/j.tmaid.2017.04.005 · DOI
- Arnold J, Alving AS, Hockwald RS, Clayman CB, Dern RJ, Beutler E, Flanagan CL, Jeffery GM. 1955. The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria (Panama, P-F-6 strain). J Lab Clin Med 46:391–397.
- 10.1086/424663 · DOI · Paper page
- 10.4269/ajtmh.1963.12.121 · DOI · Paper page
- 10.4269/ajtmh.1977.26.1116 · DOI
- 10.1093/cid/ciy735 · DOI
- Clyde DF. 1981. Clinical problems associated with the use of primaquine as a tissue schizontocidal and gametocytocidal drug. Bull World Health Organ 59:391–395.
- 10.1001/jama.1952.72930340022010b · doi:10.1001/jama.1952.72930340022010b
- 10.1001/jama.1952.72930340027010c · doi:10.1001/jama.1952.72930340027010c
- Edgcomb JH, Arnold J, Yount EH, Alving AS, Eichelberger L, Jeffery GM, Eyles D, Young MD. 1950. Primaquine, SN 13272, a new curative agent in vivax malaria: a preliminary report. J Natl Malar Soc 9:285–292.
- Beutler E. 1959. The hemolytic effect of primaquine and related compounds: a review. J Hematol 24:103–139.
- Brennecke FE, Alving AS, Arnold J, Bergenstal DM, DeWind LT. 1951. A preliminary report on the effect of certain 8-aminoquinolines in the treatment of rheumatoid arthritis. J Lab Clin Med 38:795–796.
- 10.1111/j.1749-6632.1968.tb11938.x · doi:10.1111/j.1749-6632.1968.tb11938.x
- 10.1111/j.1365-2125.1974.tb00235.x · DOI
- 10.1016/0006-2952(86)90145-0 · doi:10.1016/0006-2952(86)90145-0
- 10.1016/0006-2952(86)90144-9 · doi:10.1016/0006-2952(86)90144-9
- 10.1371/journal.pone.0105217 · doi:10.1371/journal.pone.0105217
- 10.1016/j.exphem.2013.04.002 · DOI
- 10.1073/pnas.1310402110 · doi:10.1073/pnas.1310402110
- 10.4269/ajtmh.16-0779 · DOI · Paper page
- McChesney JD, Baker JK, Clark AM, Hufford CD. 1987. Primaquine: studies of mammalian metabolism, p 3–26. In Wernsdorfer WH, Trigg PI (ed), Primaquine: pharmacokinetics, metabolism, toxicity, and activity. John Wiley & Sons, Inc, New York, NY.
- Strother A, Bucholz J, Abu-El-Haj S, Allahyrari R, Fraser IM. 1987. Metabolism of primaquine by various animal species, p 27–48. In Wernsdorfer WH, Trigg PI (ed), Primaquine: pharmacokinetics, metabolism, toxicity, and activity. John Wiley & Sons, Inc, New York, NY.
- Fletcher KA, Price AH, Barton PF. 1987. The pharmacokinetics and biochemical pharmacology of primaquine in rhesus monkeys and rats, p 49–64. In Wernsdorfer WH, Trigg PI (ed), Primaquine: pharmacokinetics, metabolism, toxicity, and activity. John Wiley & Sons, Inc, New York, NY.
- 10.1023/A:1016305822808 · doi:10.1023/a:1016305822808
- 10.1016/0006-2952(88)90263-8 · DOI
- 10.1016/S0021-9258(19)50504-X · DOI · Paper page
- 10.1186/1475-2875-12-212 · DOI · Paper page
- 10.1128/AAC.00015-15 · doi:10.1128/aac.00015-15
- 10.1186/s12936-018-2433-z · doi:10.1186/s12936-018-2433-z
- 10.1016/S0940-2993(99)80010-4 · doi:10.1016/s0940-2993(99)80010-4
- 10.1111/j.1365-2125.1984.tb02369.x · DOI · Paper page
- 10.1016/j.pharmthera.2016.03.011 · DOI · Paper page
- 10.1056/NEJMc1301936 · DOI · Paper page
- 10.1001/jamanetworkopen.2018.1449 · DOI · Paper page
- 10.1186/1475-2875-13-2 · doi:10.1186/1475-2875-13-2
- 10.1186/s12936-016-1145-5 · DOI
- 10.1186/s12936-016-1632-8 · DOI
- 10.1128/aac.48.4.1329-1334.2004 · DOI
- 10.4269/ajtmh.1958.7.207 · doi:10.4269/ajtmh.1958.7.207
- 10.4269/ajtmh.1999.60.831 · DOI
- 10.1111/j.1365-2915.1991.tb00523.x · doi:10.1111/j.1365-2915.1991.tb00523.x
- 10.4269/ajtmh.1991.44.564 · DOI
- 10.1016/0035-9203(91)90012-n · DOI · Paper page
- 10.1016/0035-9203(90)90258-g · DOI · Paper page
- 10.1016/0035-9203(76)90132-2 · DOI
- Garnham P, Bray RS, Bruce-Chwatt LJ, Draper CC, Killick-Kendrick R, Sergiev PG, Tiburskaja NA, Shute PG, Maryon M. 1975. A strain of Plasmodium vivax characterized by prolonged incubation: morphological and biological characteristics. Bull World Health Organ 52:21–32.
- 10.4269/ajtmh.1986.35.263 · doi:10.4269/ajtmh.1986.35.263
- 10.1155/2014/347018 · doi:10.1155/2014/347018
- 10.1128/CDLI.8.5.891-894.2001 · doi:10.1128/cdli.8.5.891-894.2001
- 10.1016/j.chom.2015.02.011 · DOI · Paper page
- 10.1016/j.chom.2018.01.002 · DOI
- 10.1371/journal.pntd.0002882 · DOI · Paper page
- 10.4269/ajtmh.1949.s1-29.203 · DOI
- 10.1371/journal.pntd.0003595 · DOI · Paper page
- 10.1371/journal.pmed.1001891 · DOI · Paper page
- 10.1016/s0035-9203(98)91034-3 · doi:10.1016/s0035-9203(98)91034-3
- 10.1016/s0035-9203(98)90814-8 · DOI
- 10.1080/00034989957790 · doi:10.1080/00034989957790
- 10.1371/journal.pntd.0001979 · DOI
- 10.7554/eLife.04692 · DOI · Paper page
- 10.4269/ajtmh.2001.64.97 · DOI · Paper page
- 10.1016/j.pt.2007.08.011 · DOI · Paper page
- 10.4269/ajtmh.2007.77.79 · DOI · Paper page
- 10.1590/S0037-86822007000400026 · DOI
- 10.1016/j.ijpara.2012.06.006 · doi:10.1016/j.ijpara.2012.06.006
- 10.1038/177815a0 · doi:10.1038/177815a0
- Ambruster HW. 1947. Treason’s peace: German dyes & American dupes, p 420. The Beechhurst Press, New York, NY.
- Ehrlich P. 1880. Methodologische Beiträge zur Physiologie und Pathologie der verschiedenen Formen der Leukocyten. Z Klin Med 1:553–560.
- Guttman P, Ehrlich P. 1891. Euber die Wirkung des Methylenblau bei Malaria. Berlin Klin Wochenschr 28:953–956.
- 10.1007/s00436-012-2886-x · DOI · Paper page
- Dascombe MJ, Drew MGB, Evans PG, Ismail FMD. 2007. Rational design strategies for the development of synthetic quinolone and acridine based antimalarials, p 559–609. In Atta-ur-Rahman, Caldwell GW, Choudhary MI, Player MR (ed), Frontiers in drug design & discovery, vol 3. Bentham Science Publishers, Sharjah, United Arab Emirates.
- 10.1017/mdh.2013.69 · DOI
- 10.1093/jhmas/jrv009 · DOI
- Taylor N. 1945. Cinchona in Java, p 87. Greenberg: Publisher, New York, NY.
- van Leersum N. 1945. Chapters in the history of cinchona. III. Junghuhn and cinchona cultivation, p 190–196. In Science and scientists in the Netherlands Indies. Board for the Netherlands Indies, Surinam and Curacao, New York, NY, and Riverside Press, Cambridge, MA.
- Sergent ED, Sergent ET. 1921. Avantages de la quinisation preventive demontres et precises experimentellement (Paludisme des oiseaux). Ann Inst Pasteur 35:125–141.
- 10.1353/bhm.2005.0092 · doi:10.1353/bhm.2005.0092
- Hewitt R. 1940. Bird malaria, p 228. The American Journal of Hygiene monograph series no. 15. The Johns Hopkins Press, Baltimore, MD.
- Roehl W. 1926. Die Wirkung des Plasmochins auf die Vogelmalaria. Arch Schiffs Tropenhyg 30:311–318.
- 10.4269/ajtmh.1955.4.208 · doi:10.4269/ajtmh.1955.4.208
- Field JW. 1938. Notes on the chemotherapy of malaria. VI. Synthetic gametocides of the plasmoquine type. Bull Inst Medical Res Federated Malay States 2:63–79.
- Vad BG, Mohile GB. 1927. The place of plasmochin in the treatment of malaria. Ind Med Gaz 62:430–434.
- Manson-Bahr P. 1927. The action of plasmochin on malaria. Proc R Soc Med 20:919–926.
- Sinton JA, Bird W. 1928. Studies in malaria, with special reference to treatment. Part IX. Plasmoquine in the treatment of malaria. Indian J Med Res 16:159–177.
- Cordes W. 1927. Observations on the toxic effects of plasmochin, p 62–67. In Sixteenth annual report of the Medical Department of the United Fruit Company. United Fruit Company, Boston, MA.
- Brosius OT. 1927. Plasmochin in malaria, p 26–53. In Sixteenth annual report of the Medical Department of the United Fruit Company. United Fruit Company, Boston, MA.
- 10.4269/ajtmh.1947.s1-27.309 · doi:10.4269/ajtmh.1947.s1-27.309
- 10.1172/JCI101947 · doi:10.1172/jci101947
- Sinton JA, Smith S, Pottinger D. 1930. Studies on malaria with special reference to treatment. XII. Further researches into the treatment of chronic benign tertian malaria with plasmoquine and quinine. Indian J Med Res 17:793–814.
- 10.1172/JCI101963 · doi:10.1172/jci101963
- Alving AS, Arnold J, Hockwald RS, Clayman CB, Dern RJ, Beutler E, Flanagan CL. 1955. Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine. J Lab Clin Med 46:301–306.
- Phelps BM. 1927. Clinical results with plasmochin, p 70–76. In Sixteenth annual report of the Medical Department of the United Fruit Company. United Fruit Company, Boston, MA.
- 10.1186/1475-2875-10-212 · doi:10.1186/1475-2875-10-212
- 10.1128/aac.27.2.151 · doi:10.1128/aac.27.2.151
- 10.4269/ajtmh.2011.11-0498 · doi:10.4269/ajtmh.2011.11-0498
- MacPhail NP. 1927. Plasmochin in malaria, p 67–69. In Sixteenth annual report of the Medical Department of the United Fruit Company. United Fruit Company, Boston, MA.
- 10.1172/JCI101948 · doi:10.1172/jci101948
- Shannon JA. 1945. Study of the curative action of plasmochin in vivax malaria, p 38. In Malaria report #358, parts 1 and II. 16 March. Board for the Coordination of Malaria Studies, Washington, DC.
- 10.1172/JCI101950 · doi:10.1172/jci101950
- 10.1172/JCI101955 · doi:10.1172/jci101955
- Lysenko AY. 1960. Use of quinocide in the treatment and prophylaxis of vivax malaria. Bull World Health Organ 22:641–662.
- Alving AS, Eichelberger L, Arnold J, Edgcomb J. 1949. The clinical testing of antimalarial drugs at Stateville Penitentiary. In Semi-annual report 1948-49. NIH malaria report no. 87. National Academy of Sciences Archive for the Board for Coordination of Malaria Studies, Washington, DC.
- 10.1128/AAC.03704-14 · DOI
- 10.1128/AAC.02794-13 · doi:10.1128/aac.02794-13
- 10.1128/AAC.03829-14 · doi:10.1128/aac.03829-14
- 10.1093/jac/dky297 · doi:10.1093/jac/dky297
- 10.1186/s12936-016-1509-x · doi:10.1186/s12936-016-1509-x
- Sinton JA. 1927. Studies in malaria with special reference to treatment. Part VII. The intravenous infection of sodium stovarsol in the treatment of benign tertian malaria. Indian J Med Res 15:287–299.
- 10.1126/science.101.2624.377 · doi:10.1126/science.101.2624.377
- 10.4269/ajtmh.1953.2.970 · doi:10.4269/ajtmh.1953.2.970
- 10.4269/ajtmh.1996.55.243 · DOI · Paper page
- Jensen M, Mehlhorn H. 2009. 75 years of resochin in the fight against malaria, p 102. Dusseldorf University Press, Dusseldorf, Germany.
- Sweeney T. 2003. Malaria frontline: Australian Army research during World War II, p 398. Melbourne University Press, Melbourne, Australia.
- 10.1001/jama.1943.82840390004007 · doi:10.1001/jama.1943.82840390004007
- Butler AM. 1945. Clinical toxicity of plasmocide (SN-3115; rhodoquine): review of the Russian and French literature, p 8. In Malaria report no. 401. 9 May. Board for the Coordination of Malarial Studies. Washington, DC.
- 10.1097/00005072-194810000-00002 · doi:10.1097/00005072-194810000-00002
- Schmidt LH. 1945. The toxicities of the 8-aminoquinolines: relation of structure to the toxicity of these drugs for the monkey, p 19. In Malaria report no. 469. 19 July. Board for the Coordination of Malarial Studies. Washington, DC.
- 10.1172/JCI101973 · doi:10.1172/jci101973
- 10.1172/JCI101956 · doi:10.1172/jci101956
- 10.1093/oxfordjournals.aje.a119180 · doi:10.1093/oxfordjournals.aje.a119180
- 10.4269/ajtmh.1953.2.977 · doi:10.4269/ajtmh.1953.2.977
- 10.4269/ajtmh.1953.2.985 · doi:10.4269/ajtmh.1953.2.985
- 10.1021/ja01212a039 · doi:10.1021/ja01212a039
- 10.4269/ajtmh.1953.2.949 · doi:10.4269/ajtmh.1953.2.949
- 10.1172/JCI101970 · doi:10.1172/jci101970
- 10.1001/jama.1952.72930340021010a · doi:10.1001/jama.1952.72930340021010a
- 10.1001/jama.1952.72930340017010 · doi:10.1001/jama.1952.72930340017010
- 10.1001/jama.1954.02940510011005 · doi:10.1001/jama.1954.02940510011005
- 10.1172/JCI101949 · doi:10.1172/jci101949
- 10.1385/1-59259-111-6:123 · doi:10.1385/1-59259-111-6:123
- 10.4269/ajtmh.1998.58.645 · DOI · Paper page
- Davidson DE, Jr, Ager AL, Brown BL, Chapple FE, Whitmire RE, Rossan RN. 1981. New tissue schizontocidal antimalarial drugs. Bull World Health Organ 59:463–479.
- 10.4269/ajtmh.1970.19.27 · doi:10.4269/ajtmh.1970.19.27
- 10.1016/S1471-4922(03)00005-9 · DOI · Paper page
- Schultz MG. 1974. Imported malaria. Bull World Health Organ 50:329–336.
- 10.4269/ajtmh.1969.18.495 · doi:10.4269/ajtmh.1969.18.495
- 10.1186/1475-2875-11-122 · DOI · Paper page
- 10.7205/milmed.170.4s.12 · DOI
- 10.1016/0020-711X(84)90086-7 · doi:10.1016/0020-711x(84)90086-7
- 10.1016/0020-711X(84)90087-9 · doi:10.1016/0020-711x(84)90087-9
- 10.1016/0272-0590(88)90311-9 · doi:10.1016/0272-0590(88)90311-9
- 10.1021/jm00351a017 · doi:10.1021/jm00351a017
- 10.1021/jm00390a012 · doi:10.1021/jm00390a012
- 10.1021/jm00351a018 · doi:10.1021/jm00351a018
- 10.4269/ajtmh.1989.40.235 · doi:10.4269/ajtmh.1989.40.235
- Marino MT, Peggins JO, Brown LD, Urquhart MR, Brewer TG. 1994. Pharmacokinetics and kinetic-dynamic modelling of an 8-aminoquinoline candidate anticyanide and antimalarial drug (WR242511). Drug Metab Dispos 22:358–366.
- 10.1177/014107689909200705 · doi:10.1177/014107689909200705
- 10.1007/BF03161194 · doi:10.1007/bf03161194
- 10.1128/AAC.42.5.1293 · doi:10.1128/aac.42.5.1293
- 10.1086/315034 · doi:10.1086/315034
- 10.1086/324081 · DOI · Paper page
- 10.1016/S0140-6736(00)02352-7 · DOI
- Edstein MD, Walsh DS, Eamsila C, Sasiprapha T, Nasveld PE, Kitchener S, Reickmann KH. 2001. Malaria prophylaxis/radical cure: experiences of the Australian Defence Force. Med Trop (Mars) 61:56–58.
200 of 322 shown
Cited by
Plasmodium—a brief introduction to the parasites causing human malaria and their basic biology
Sato, S. (2021) · Journal of Physiological Anthropology · doi:10.1186/s40101-020-00251-9 · Cited by 404
Plasmodium vivax in the Era of the Shrinking P. falciparum Map
Price, R. N., Commons, R. J., Battle, K. E., Thriemer, K., & Mendis, K. (2020) · Trends in Parasitology · doi:10.1016/j.pt.2020.03.009 · Cited by 269
Satyagraha, A. W., Sadhewa, A., Panggalo, L. V., Subekti, D., Elyazar, I., Soebianto, S., Mahpud, N., Harahap, A. R., & Baird, J. K. (2021) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0009610 · Cited by 12
Self-citationShifraw, T., Abdelmenan, S., Zewde, A., Worku, A., Abera, A., Mohammed, H., Etana, K., Keating, J., Chibsa, S., Girma, S., et al. (2025) · Malaria Journal · doi:10.1186/s12936-025-05709-8
Metadata
- Authors
- Baird, J. K.
- Affiliations
- Eijkman-Oxford Clinical Research Unit, Eijkman Institute for Molecular Biology, Jakarta, Indonesia
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2019-09-18
- Volume
- 32
- Issue
- 4
- ISSN
- 0893-8512
- 1098-6618
- Cited by
- 122
- References
- 12
- Language
- en
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Funders
- United Kingdom Clinical Research Collaboration (ABCDEFG123456)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 8-Aminoquinoline Therapy for Latent Malaria. https://app.cochat.ai/papers/10.1128/cmr.00011-19
- The paper
- Baird, J. K. (2019). 8-Aminoquinoline Therapy for Latent Malaria. Clinical Microbiology Reviews. https://doi.org/10.1128/cmr.00011-19
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.